Solstein Capital’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Solstein Capital’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-33	Closed	-$1K	–	367
2022 Q1	$1K	Hold	33	–	–	﹤0.01%	373
2021 Q4	$1K	Hold	33	–	–	﹤0.01%	409
2021 Q3	$1K	Hold	33	–	–	﹤0.01%	449
2021 Q2	$1K	Buy	+33	New	+$853	﹤0.01%	432

Other funds holding FTXH

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Solstein Capital's FTXH Position: Q2 2022 in Review

Solstein Capital sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2022, closing a stake of 33 shares — an estimated $1K sold.

Solstein Capital first reported a position in FTXH in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 20 funds tracked by Wall St. Rank hold FTXH as of Q2 2022.

Solstein Capital reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
Solstein Capital sold 33 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2022, an estimated $1K.
Solstein Capital first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2021 and held it in 4 quarters.
Solstein Capital's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1K in Q1 2022.
20 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2022.

Based on Solstein Capital's 13F filing for Q2 2022, filed 9 Aug 2022.